Register entry
- Registered sites
- 1
- Active NDC listings
- 9
- Labeller names
- 4
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Samson Pharmaceuticals, Inc. | 5635 Smithway St, Commerce, California (CA) 90040, United States (USA) | Labelling, Finished drug manufacture, Packaging | 3005644727088169581 |
Catalogue
Drug listings by form and route
99 active NDC listings: 6 human prescription drug, 3 human otc drug. By marketing category: ANDA 6, OTC MONOGRAPH DRUG 3.
| Dosage form | NDCs |
|---|---|
| injection, powder, for solution | 3 |
| injection, powder, lyophilized, for solution | 3 |
| lotion | 2 |
| solution/ drops | 1 |
| Route | NDCs |
|---|---|
| intravenous | 6 |
| topical | 2 |
| ophthalmic | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| samson medical technologies llc | 3 |
| samson pharmaceutical | 3 |
| samson medical technologies, l.l.c. | 2 |
| samson medical technologies, llc | 1 |
Catalogue
Marketed products
9| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CEFAZOLIN | CEFAZOLIN SODIUM | injection, powder, lyophilized, for solution, intravenous | 66288-1100ANDA |
| CEFAZOLIN | CEFAZOLIN SODIUM | injection, powder, lyophilized, for solution, intravenous | 66288-1300ANDA |
| CEFEPIME | CEFEPIME | injection, powder, for solution, intravenous | 66288-8100ANDA |
| Cefoxitin | cefoxitin | injection, powder, for solution, intravenous | 66288-4100ANDA |
| Ceftriaxone | Ceftriaxone Sodium | injection, powder, for solution, intravenous | 66288-6100ANDA |
| LA Bodies Eclipse Sunscreen SPF 30 | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone | lotion, topical | 20146-4007OTC MONOGRAPH DRUG |
| LA Bodies Eclipse Sunscreen SPF 50 | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone | lotion, topical | 20146-4008OTC MONOGRAPH DRUG |
| Pure Eyes Sterile Eyes | Naphazoline Hydrochloride and Glycerin | solution/ drops, ophthalmic | 20146-7000OTC MONOGRAPH DRUG |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 66288-7100ANDA |
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Samson Pharmaceuticals, Inc. FDA approved?
- Samson Pharmaceuticals, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Samson Pharmaceuticals, Inc.'s drugs manufactured?
- The FDA register lists Commerce, CA. Registered operations: labelling, finished drug manufacture, packaging.
- What drugs does Samson Pharmaceuticals, Inc. make?
- 9 products are listed under Samson Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, powder, for solution; injection, powder, lyophilized, for solution; lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.